Abettor Life Sciences Private Limited
About Abettor Life Sciences Private Limited
Data last updated:
Abettor Life Sciences Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2012PTC145440. Its GSTIN is 27AALCA1315J1ZS (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandrakant Mahadeo Morti and Jaisingh Khatri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gat No 1262 Milkat No 1340 Ward No 2 Datta Nagar Wadki, Pune, Maharashtra, India – 412308.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.43 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹8.02 Lakh (net margin 3.3%) and EBITDA of ₹17.55 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 10% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹84 Lakh and satisfied charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGat No 1262 Milkat No 1340 Ward No 2 Datta Nagar Wadki, Pune, Maharashtra, India – 412308
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Abettor Life Sciences Private Limited
The main business activity of Abettor Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Abettor Life Sciences Private Limited FY 2024 filings available
Abettor Life Sciences Private Limited reported revenue of ₹2.43 Cr (up 42% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Abettor Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 42% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Abettor Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.55 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.02 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Abettor Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Abettor Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Abettor Life Sciences Private Limited
Abettor Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cytochrome Life Sciences Private Limited | ₹2.44 Cr (FY 2023) | •••• | •••• | 25.0% | •••• | Delhi, India |
| Galveston Healthcare Private Limited | ₹2.44 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Varanasi, Uttar Pradesh, India |
| Cure Day Healthcare Private Limited | ₹2.44 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Zirakpur, Punjab, India |
| Fly Wings Marketing International (OPC) Private Limited | ₹2.43 Cr (FY 2018) | •••• | •••• | -28.0% | •••• | Nagpur, Maharashtra, India |
| Om Shubham Pharmaceuticals Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Kanpur, Uttar Pradesh, India |
| Abettor Life Sciences Private Limited this company | ₹2.43 Cr (FY 2023) | •••• | •••• | 42.0% | •••• | Pune, Maharashtra, India |
| Sri Naga Sai Healthcare Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Bangalore, Karnataka, India |
| Render & Mech Formulations Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Chennai, Tamil Nadu, India |
| Zumanix Remedies Private Limited | ₹2.43 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Raipur, Chhattisgarh, India |
| Today's Drugs Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Howrah, West Bengal, India |
| Dansk Pharmaceuticals India Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Faridabad, Haryana, India |
Peers are the five companies nearest above and the five nearest below Abettor Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Abettor Life Sciences Private Limited
Abettor Life Sciences Private Limited is audited by VANDAN SHAH & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VANDAN SHAH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Abettor Life Sciences Private Limited
Abettor Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrakant Mahadeo Morti Also directs: Abettor Healthcare LLP | Director | 20 Nov 2012 | 13 Years 10 Months | Current |
| Jaisingh Khatri Also directs: Abettor Healthcare LLP | Director | 20 Nov 2012 | 13 Years 10 Months | Current |
Ownership and Shareholding of Abettor Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Abettor Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2020 | Others | ₹4 Lakh | Open |
| 31 Mar 2018 | Others | ₹80 Lakh | Open |
| 05 Nov 2015 | Bank of Baroda | ₹10 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Abettor Life Sciences Private Limited
Abettor Life Sciences Private Limited has a workforce of 22 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Abettor Life Sciences Private Limited
Abettor Life Sciences Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Parag Bajirao Kaduskar ceased to be Director on 29 Mar 2014.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Abettor Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Abettor Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abettor Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Abettor Life Sciences Private Limited
Abettor Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCA1315J1ZS | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abettor Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abettor Life Sciences Private Limited
Abettor Life Sciences is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 November 2012 (14+ years old) and is registered under CIN U74900PN2012PTC145440.
Abettor Life Sciences reported revenue of ₹2.43 Cr for FY 2023 (up 42% YoY).
Abettor Life Sciences has 2 current directors:
- Chandrakant Mahadeo Morti - Director
- Jaisingh Khatri - Director
Abettor Life Sciences reported a net profit of ₹8.02 Lakh (net margin 3.3%) and EBITDA of ₹17.55 Lakh (EBITDA margin 7.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Abettor Life Sciences is 14% over three years and 10% over five years. In the latest year (FY 2023) revenue rose 42%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Abettor Life Sciences is 27AALCA1315J1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Abettor Life Sciences is U74900PN2012PTC145440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abettor Life Sciences was incorporated on 20 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Abettor Life Sciences by revenue are Cytochrome Life Sciences Private Limited, Galveston Healthcare Private Limited, Cure Day Healthcare Private Limited, Fly Wings Marketing International (OPC) Private Limited, Om Shubham Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Parag Bajirao Kaduskar ceased to be Director on 29 Mar 2014. Sachin Mahadev Tawaskar ceased to be Director on 29 Mar 2014. Jitendra Prakash Mantri ceased to be Director on 21 Mar 2013. Abettor Life Sciences has 5 board changes on record in total.
The registered office of Abettor Life Sciences is at Gat No 1262 Milkat No 1340 Ward No 2 Datta Nagar Wadki, Pune, Maharashtra, India – 412308.